AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2444309
Drug: Fresh frozen
RxNorm normalized name: Fresh frozen plasma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresh frozen plasma (FFP) - 2 units daily for 3 days
Trial: 26907840
Drug: Concurrent Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent Strength and Endurance Training 3:1 (CT3)
Trial: 26907840
Drug: Concurrent Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent Strength and Endurance Training 1:1 (CT1)
Trial: 22147112
Drug: BAY41-6551 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY41-6551 400 mg every 24 hours (q24h) with aerosol placebo
Trial: 17845589
Drug: Beclomethasone plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone plus formoterol combination
Trial: 772759
Drug: Indomethacin (therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (therapeutic doses)
Trial: 772759
Drug: Acetyl salicylic
RxNorm normalized name: Acetyl salicylic acid specific IgE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl salicylic acid (therapeutic doses)
Trial: 17720659
Drug: LPV/r 400/300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LPV/r 400/300 mg bid
Trial: 17720659
Drug: LPV/r 667/167
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LPV/r 667/167 mg bid
Trial: 10575912
Drug: Omeprazole with
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole with amoxicillin and clarithromycin
Trial: 10575912
Drug: Colloidal bismuth
RxNorm normalized name: Colloidal bismuth subcitrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colloidal bismuth with amoxicillin and metronidazole
Trial: 6614325
Drug: Metronidazole (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (500 mg intravenously before operation)
Trial: 6614325
Drug: Ticarcillin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticarcillin (5 g intravenously before operation)
Trial: 17165349
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine 1.5 mg/kg
Trial: 30741832
Drug: Intravenous esmolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous esmolol 0.5 mg/kg and lidocaine 1.5 mg/kg
Trial: 16456408
Drug: Proton pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton pump inhibitor
Trial: 23028897
Drug: 100 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 µg selenium/d
Trial: 23028897
Drug: 200 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 µg selenium/d
Trial: 23028897
Drug: 300 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 µg selenium/d
Trial: 20137761
Drug: Cilostazol 100
RxNorm normalized name: cilostazol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilostazol 100 mg b.i.d for 7 days along with standard doses of aspirin and clopidogrel
Trial: 18608093
Drug: Minocycline (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minocycline (100 mg) - Creatine (10 g) twice daily for six months
Trial: 16102404
Drug: 2-phase treatment
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 2-phase treatment (full orthodontic treatment with fixed appliances after 1 year)
Trial: 10872368
Drug: Radical anterior
RxNorm normalized name: Campsis radicans flower extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radical anterior resection with bone grafting plus six months of daily isoniazid plus rifampicin (Rad6)
Trial: 23474245
Drug: Intensified antihypertensive
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensified antihypertensive therapy
Trial: 1759583
Drug: Topical glucocorticoids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical glucocorticoids
Trial: 21724155
Drug: Medicine for
RxNorm normalized name: IBUPROFEN 200 mg ORAL TABLET [Ibuprofen Fast relief medicine for pain]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medicine for the Earth (MFTE)
Trial: 22964475
Drug: Calcium (2
RxNorm normalized name: calcium (2ξ)-D-gluco-heptonate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (2 g/day)
Trial: 11722712
Drug: Immune milk
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immune milk treatment (45 g of immune milk powder twice a day for 3 months)
Trial: 11722712
Drug: Immune milk
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immune milk treatment
Trial: 11722712
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (oral habit intervention only)
Trial: 9220212
Drug: cilazapril plus
RxNorm normalized name: cilazapril
DrugBank: Cilazapril (DB01340)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cilazapril plus conventional therapy (diuretics and digitalis)
Trial: 9220212
Drug: conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: conventional therapy (diuretics and digitalis)
Trial: 31230020
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg melatonin per day
Trial: 25929739
Drug: Vildagliptin 50
RxNorm normalized name: vildagliptin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vildagliptin 50 mg b.i.d.
Trial: 23782529
Drug: Glimepiride 2
RxNorm normalized name: glimepiride 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glimepiride 2 mg q.d.
Trial: 16967045
Drug: Fluticasone nasal
RxNorm normalized name: fluticasone nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone nasal 50 microg/spray b.i.d. and Fenoxifenadine 180 mg tablets q.d.
Trial: 12775344
Drug: Altered synaptic
RxNorm normalized name: Synanthic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Altered synaptic inactivity due to changes in glycoconjugate metabolism and membrane composition.
Trial: 22091738
Drug: CAPABLE intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CAPABLE intervention (occupational therapy, nursing, handyman visits)
Trial: 19631127
Drug: Adrenaline group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adrenaline group (0.5 mL of 1:1000 adrenaline in 500.0 mL of fortified balanced salt solution)
Trial: 29273872
Drug: Lansoprazole orally
RxNorm normalized name: Lansoprazole
DrugBank: Lansoprazole (DB00448)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lansoprazole orally disintegrating (OD) tablets (30 mg) given orally once daily for 8 weeks (56 days) starting the day before ESD
Trial: 20693267
Drug: Nutrient and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrient and supplement intakes (lycopene, long-chain n-3 fatty acids, vitamin D, vitamin E, selenium)
Trial: 9374251
Drug: Latanoprost 50
RxNorm normalized name: Latanoprost 50 microgram/mL eye drops
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Latanoprost 50 microg/ml, one drop twice daily
Trial: 3893619
Drug: Phenol Injection
RxNorm normalized name: Phenol Injection
DrugBank: Phenol (DB03255)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenol Injection
Trial: 20530437
Drug: Vaginal micronized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal micronized progesterone at 400 mg daily for 10 days/month for 6 months
Trial: 10595786
Drug: Beta-carotene (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-carotene (15 mg/day)
Trial: 10595786
Drug: Lycopene (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lycopene (15 mg/day)
Trial: 27736846
Drug: Paclitaxel treatment
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel treatment
Trial: 27566263
Drug: Alectinib 150
RxNorm normalized name: alectinib 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alectinib 150 mg capsule
Trial: 27566263
Drug: Alectinib 20/40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alectinib 20/40 mg capsules
Trial: 2907315
Drug: Nitrazepam 10
RxNorm normalized name: nitrazepam 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrazepam 10 mg
Trial: 331868
Drug: Nitrazepam 5
RxNorm normalized name: nitrazepam 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrazepam 5 mg and 10 mg
Trial: 26094394
Drug: Dietary supplement
RxNorm normalized name: dietary supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary supplement rekicen‐RD® in combination with antibacterial therapy
Trial: 15035551
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of terbutaline daily for 15 days starting on the day of oocyte retrieval (Group I)
Trial: 15035551
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of ritodrine daily for 15 days (Group II)
Trial: 7092752
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (Group III)
Trial: 7697065
Drug: Tricyclic antidepressants
RxNorm normalized name: TRICYCLIC ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tricyclic antidepressants or cognitive-behavioral psychotherapy
Trial: 30482676
Drug: Herbal tea
RxNorm normalized name: Senna Oral Powder for Suspension [CORRECTOL HERBAL TEA LAXATIVE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal tea (Astragali Radix, Angelicae gigantis Radix, Zizyphi Fructus) consumed twice daily for 4 weeks
Trial: 6118171
Drug: Atenolol 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 0.2 mg/kg
Trial: 6118171
Drug: Betaxolol 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betaxolol 0.15 mg/kg
Trial: 6118171
Drug: Betaxolol 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betaxolol 0.6 mg/kg
Trial: 436923
Drug: Practolol 1
RxNorm normalized name: (±)-practolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Practolol 1 mg/kg
Trial: 26710009
Drug: Silicone implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silicone implants
Trial: 26710009
Drug: Saline implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline implants
Trial: 11869201
Drug: Long pulse
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long pulse 532 nm potassium tritanyl phosphate (KTP) laser treatment for perialar vessels
Trial: 11869201
Drug: Long pulse
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long pulse 532 nm potassium tritanyl phosphate (KTP) laser treatment for spider naevi
Trial: 9022602
Drug: Oral estrone
RxNorm normalized name: Estrone
DrugBank: Estrone sulfate (DB04574)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral estrone sulfate
Trial: 8566257
Drug: Transdermal E2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal E2
Trial: 23367230
Drug: NMES therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NMES therapy of quadriceps femoris and tibialis anterior muscles
Trial: 18497346
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg oral mifepristone
Trial: 15587176
Drug: Ropivacaine 0.9375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 0.9375 mg x kg(‐1)
Trial: 15587176
Drug: Ropivacaine 0.5625
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 0.5625 mg x kg(‐1)
Trial: 10689949
Drug: Prednisolone (maximum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (maximum of 15 mg daily)
Trial: 3276591
Drug: Nadolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadolol (40 to 120 mg per day)
Trial: 21707560
Drug: Clonidine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (150 μg) added to epidural solution
Trial: 14980556
Drug: Sulpiride (dopaminergic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulpiride (dopaminergic drug treatment)
Trial: 9273190
Drug: Concomitant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant chemotherapy with daily doses of carboplatin (20 to 25 mg/m2/d over 45 or 10 min) and accelerated chest irradiation (60 to 64 Gy over 4 weeks, 2 Gy per fraction)
Trial: 9273190
Drug: Concomitant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant chemotherapy with daily doses of carboplatin and accelerated chest irradiation
Trial: 3306068
Drug: Danazol 200
RxNorm normalized name: danazol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danazol 200 mg per day
Trial: 27038608
Drug: CT-P13 (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CT-P13 (3 mg/kg)
Trial: 27038608
Drug: RP (3
RxNorm normalized name: Ropinirole
DrugBank: Ropinirole (DB00268)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: RP (3 mg/kg)
Trial: 19947898
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg quercetin/day with 125 mg vitamin C/day
Trial: 19947898
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg quercetin/day with 250 mg vitamin C/day
Trial: 20428412
Drug: Duloxetine 60/120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 60/120 mg once daily
Trial: 10397378
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of 600 mg clomethiazole edisylate (390 mg clomethiazole base)
Trial: 10397378
Drug: Both oral
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both oral and rectal administration of 600 mg clomethiazole edisylate
Trial: 31869656
Drug: Primary care-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primary care-based treatment
Trial: 18579924
Drug: Both active
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both active and sham treatments
Trial: 18579924
Drug: Monochromatic infrared
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monochromatic infrared energy treatment
Trial: 16007595
Drug: Chemotherapy (specific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (specific dosage and duration not provided)
Trial: 12401632
Drug: Clonidine 15-45
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine 15-45 micro g
Trial: 10667283
Drug: Amitriptyline (AMI)
DrugBank: Amitriptyline (DB00321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amitriptyline (AMI) at 1.6 mg/kg/day
Trial: 2082953
Drug: Hydergine‐LC (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydergine‐LC (1 mg orally three times daily for 24 weeks)
Trial: 30654808
Drug: Chloroquine (CQ)
RxNorm normalized name: Chloroquine
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloroquine (CQ) total 25 mg/kg over 3 days
Trial: 27605986
Drug: Buccal corticotomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buccal corticotomy
Trial: 27605986
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no buccal corticotomy)
Trial: 22623468
Drug: No intracanal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No intracanal medication (Group B)
Trial: 16006029
Drug: Citalopram (CIT)
DrugBank: Citalopram (DB00215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Citalopram (CIT) 10-80 mg/day
Trial: 29426035
Drug: Cognitive Anxiety
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Anxiety Sensitivity Treatment (CAST + cognitive bias modification)
Trial: 20811917
Drug: 25 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 μg fentanyl
Trial: 20811917
Drug: 50 μg
RxNorm normalized name: penicillin G 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 μg fentanyl
Trial: 15780701
Drug: Sertraline, 50-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline, 50-150 mg/day, continuous dosing throughout the menstrual cycle
Trial: 7223659
Drug: 160 mg
RxNorm normalized name: nadolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 mg slow release oxprenolol, once daily for 1 month
Trial: 7223659
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg propranolol, four times daily for 1 month
Trial: 7223659
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg propranolol, four times daily
Trial: 22094298
Drug: Primary surgical
RxNorm normalized name: Sodium primary phosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primary surgical treatment for advanced glaucoma
Trial: 19761838
Drug: Reformulated killed
RxNorm normalized name: Tarsum Reformulated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reformulated killed oral cholera vaccine (1 dose)
Trial: 19761838
Drug: Reformulated killed
RxNorm normalized name: Tarsum Reformulated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reformulated killed oral cholera vaccine (2 doses)
Trial: 15339752
Drug: Unopposed transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unopposed transdermal estradiol at 0.014 mg/d (n = 208)
Trial: 328033
Drug: Diflunisal 375
RxNorm normalized name: diflunisal 375 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diflunisal 375 mg twice daily
Trial: 29343131
Drug: Plecanatide 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plecanatide 6 mg
Trial: 19887582
Drug: Low serum
RxNorm normalized name: ZINC OXIDE 20 g in 100 mL TOPICAL CREAM [Sunceutical SPF 50 Mineral Glow Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low serum cholesterol (<200 mg/dL)
Trial: 9926771
Drug: HA-coated implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HA-coated implants that were mobile at placement
Trial: 9926771
Drug: Non-HA-coated implants
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-HA-coated implants that were mobile at placement
Trial: 9926771
Drug: All implants
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All implants (mobile or immobile) that integrated
Trial: 9926771
Drug: HA-coated implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HA-coated implants (mobile)
Trial: 791038
Drug: ethyl linoleate
RxNorm normalized name: Ethyl linoleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ethyl linoleate agent (hELate) applied at a dose of 25 mg/kg only once after burn
Trial: 28478975
Drug: Adalimumab 0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adalimumab 0.8 mg/kg
Trial: 22573729
Drug: Daily cigarette
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily cigarette smokers
Trial: 30973790
Drug: Tamoxifen 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 5 mg/d
Trial: 16382122
Drug: Fenretinide 200
RxNorm normalized name: FENRETINIDE
DrugBank: Fenretinide (DB05076)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenretinide 200 mg/d
Trial: 8265321
Drug: Acellular pertussis
RxNorm normalized name: Acellular pertussis vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acellular pertussis vaccines (AC)
Trial: 8265321
Drug: Monocomponent PT
RxNorm normalized name: PT-2385
DrugBank: PT-2385 (DB16055)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monocomponent PT vaccine
Trial: 3103662
Drug: Fresh gas
RxNorm normalized name: Peroxi-Fresh
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresh gas flow (FGF) of 70 ml kg‐1 min‐1
Trial: 28883225
Drug: Carvedilol (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (2.5 mg/5 mg/20 mg)
Trial: 23363386
Drug: Levothyroxine administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levothyroxine administration with breakfast
Trial: 25179689
Drug: palonosetron 0.25
RxNorm normalized name: palonosetron 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: palonosetron 0.25 mg
Trial: 14504060
Drug: ondansetron 32
RxNorm normalized name: ondansetron 32 MG in 50 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ondansetron 32 mg
Trial: 10893654
Drug: Cizolirtine citrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cizolirtine citrate (E-4018) 50 mg
Trial: 10893654
Drug: Cizolirtine citrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cizolirtine citrate (E-4018) 100 mg
Trial: 10893654
Drug: Cizolirtine citrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cizolirtine citrate (E-4018) 150 mg
Trial: 4022214
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E supplementation (600 mg daily for 30 days)
Trial: 25247929
Drug: Intravenous ferric‐carboxymaltose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ferric‐carboxymaltose (2 ml, 100 mg)
Trial: 20007337
Drug: Flaxseed bread
RxNorm normalized name: FLAXSEED
DrugBank: Flax seed (DB10708)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed bread (25 g of flaxseed, 46 mg lignans)
Trial: 12792350
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg of tenofovir DF once daily
Trial: 1847127
Drug: External beam
RxNorm normalized name: Beam
DrugBank: Tricyclazole (DB02891)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: External beam radiotherapy as hyperfractionated treatment (1.2 Gy twice daily, 4 hours separation, 5 days per week, 24.0 Gy total) with similar chemotherapy.
Trial: 1847127
Drug: Induction regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction regimen with cycles of radiolabeled antibody therapy (30 mCi I-131 antiferritin, Day 0, and 20 mCi, Day 5).
Trial: 11732382
Drug: tenoxicam 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tenoxicam 40 mg intravenously (i.v.)